Unipharm navigates tricky IPO market to raise €136m
Unipharm, the Irish healthcare services company, has managed to successfully price its €136m IPO in London and Dublin, despite price sensitivity among investors leading to the cancellation of two significant IPOs last week.
Despite equity markets reaching new all-time highs on Friday, the IPO of AB InBev’s Asian subsidiary, which would have been the largest flotation of the year, was pulled due to weak demand from institutional investors.In the UK, ReAssure, the UK closed book life insurance division of Swiss ...
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: firstname.lastname@example.org